2006
DOI: 10.1016/j.cardfail.2006.04.006
|View full text |Cite
|
Sign up to set email alerts
|

P38 MAP Kinase Activity Is Correlated With Angiotensin II Type 1 Receptor Blocker–Induced Left Ventricular Reverse Remodeling in Spontaneously Hypertensive Heart Failure Rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2008
2008
2016
2016

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(12 citation statements)
references
References 42 publications
0
12
0
Order By: Relevance
“…3134 Interestingly, both 10% stretch and IL-17a at 100 ng/mL induced p38MAP kinase phosphorylation in aortic fibroblasts (Figure 5A–C). Moreover, inhibition of p38 MAP kinase with SB203580 prevented the increase in mRNA for collagens 1a1, 3a1 and 5a1 caused by stretch (Figure 5D–5F).…”
Section: Resultsmentioning
confidence: 97%
“…3134 Interestingly, both 10% stretch and IL-17a at 100 ng/mL induced p38MAP kinase phosphorylation in aortic fibroblasts (Figure 5A–C). Moreover, inhibition of p38 MAP kinase with SB203580 prevented the increase in mRNA for collagens 1a1, 3a1 and 5a1 caused by stretch (Figure 5D–5F).…”
Section: Resultsmentioning
confidence: 97%
“…related kinase (ERK1/2), and c-Jun N-terminal kinase (JNK)]. In animal models of heart failure, activation of MAPK signaling plays a vital role in LV remodeling and treatment with ARBs reduces the activation of MAPK signaling (See et al, 2004;Liang et al, 2006), suggesting that activation of MAPK is mediated through AT 1 receptor. Moreover, Koka et al, demonstrated that treatment with AT 1 receptor blocker or blockade of ERK1/2 or MAPK by either specific inhibitor was able to abolish ANG-II-induced ACE-2 downregulation in human kidney tubular cells, suggesting that ANG-II-induced ACE-2 downregulation is associated with activation of ERK1/2 and p38 MAP kinase pathways (Koka et al, 2008).…”
Section: Discussionmentioning
confidence: 99%
“…Kumar et al have also shown that losartan does not affect P-p38 levels in isolated rat hearts exposed to ischemia-reperfusion [39], whereas AT2 inhibition by PD123,319 leads to an increase in P-p38 levels [39]. It has been shown that the ARB L-1258, 809 attenuated cardiac p38 activation in spontaneously hypertensive heart failure rats [40]. Thus, different effects of ARBs on p38 activation are seen in different experimental models.…”
Section: Cox2mentioning
confidence: 93%